Synopsis of recent research by authors named "Anna Ievko"
- Anna Ievko's recent research emphasizes the development of predictive biomarkers for cancer treatments, specifically focusing on the functional binding of PD1 ligands, PDL1 and PDL2, to assess patient responses to anti-PD1 therapies.
- The research includes the innovation of a cell-based reporting system, IcAR-PD1, which evaluates the binding functionality in various tumor models, showcasing its potential in stratifying patients for immune checkpoint inhibitor treatments.
- Additionally, Ievko has examined the safety profile of the BNT162b2 mRNA COVID-19 vaccine in cancer patients during ongoing treatment, highlighting the significance of vaccination in this vulnerable population amidst the pandemic.